PortfoliosLab logo
American Oncology Network Inc. (AONC)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

IPO Date

May 5, 2021

Highlights

Market Cap

$216.44M

EPS (TTM)

-$0.89

Total Revenue (TTM)

$1.40B

Gross Profit (TTM)

$108.46M

EBITDA (TTM)

$17.62M

Year Range

$1.01 - $8.45

Short %

0.39%

Short Ratio

0.63

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


American Oncology Network Inc.

Performance

Performance Chart


Loading data...

S&P 500

Returns By Period

American Oncology Network Inc. (AONC) returned 58.10% year-to-date (YTD) and 221.29% over the past 12 months.


AONC

YTD

58.10%

1M

26.98%

6M

83.91%

1Y

221.29%

3Y*

-6.49%

5Y*

N/A

10Y*

N/A

^GSPC (Benchmark)

YTD

0.52%

1M

6.32%

6M

-1.44%

1Y

12.25%

3Y*

12.45%

5Y*

14.20%

10Y*

10.84%

*Annualized

Monthly Returns

The table below presents the monthly returns of AONC, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20254.60%-0.62%-4.94%26.00%26.98%58.10%
2024-10.34%12.85%-8.04%-30.42%-12.57%-68.56%166.67%29.93%7.20%-20.26%39.87%16.32%-14.24%
20230.75%0.79%1.47%-1.26%0.49%0.49%2.91%-0.94%-11.60%-34.68%18.19%-17.83%-41.26%
2022-0.62%0.26%0.46%0.20%0.05%-0.05%0.41%-0.10%0.10%1.22%-0.00%1.06%3.03%
20210.94%0.52%-0.41%-0.93%0.94%0.21%0.31%-0.00%1.56%
Go deeper with the Portfolio Analysis tool — backtest performance, assess risk, compare to benchmarks, and more

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

With an overall rank of 94, AONC is among the top 6% of stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of AONC is 9494
Overall Rank
The Sharpe Ratio Rank of AONC is 9292
Sharpe Ratio Rank
The Sortino Ratio Rank of AONC is 9292
Sortino Ratio Rank
The Omega Ratio Rank of AONC is 9292
Omega Ratio Rank
The Calmar Ratio Rank of AONC is 9696
Calmar Ratio Rank
The Martin Ratio Rank of AONC is 9595
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for American Oncology Network Inc. (AONC) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

American Oncology Network Inc. Sharpe ratios as of May 30, 2025 (values are recalculated daily):

  • 1-Year: 1.69
  • All Time: -0.03

These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns (including price changes and dividends).

The chart below shows the rolling Sharpe ratio of American Oncology Network Inc. compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time.


Loading data...

Go to the full Sharpe Ratio tool to analyze any stock or portfolio. Customize time frames, set your own risk-free rate, and more

Dividends

Dividend History


American Oncology Network Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading data...

Worst Drawdowns

The table below displays the maximum drawdowns of the American Oncology Network Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the American Oncology Network Inc. was 96.38%, occurring on Jun 28, 2024. The portfolio has not yet recovered.

The current American Oncology Network Inc. drawdown is 72.41%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-96.38%Sep 19, 2023196Jun 28, 2024
-7.25%May 14, 20211May 14, 2021457Mar 9, 2023458
-2.76%Mar 10, 202315Mar 30, 202382Jul 28, 202397
-2.46%Sep 14, 20231Sep 14, 20231Sep 15, 20232
-1.41%Aug 3, 202315Aug 23, 202314Sep 13, 202329
Go to the full Drawdowns tool for more analysis options, including inflation-adjusted drawdowns, and more

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading data...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of American Oncology Network Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Earnings Per Share

The chart presents the Earnings Per Share (EPS) performance of American Oncology Network Inc., comparing actual results with analytics estimates.


-1.00-0.500.00AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024
-1.22
0
Actual
Estimate

Valuation

The Valuation section provides an overview of how American Oncology Network Inc. is priced in the market compared to other companies in the Medical Care Facilities industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for AONC relative to other companies in the Medical Care Facilities industry. Currently, AONC has a P/S ratio of 0.1. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for AONC in comparison with other companies in the Medical Care Facilities industry. Currently, AONC has a P/B value of 0.0. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items